Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.7682
+0.0261 (3.52%)
At close: Apr 28, 2026, 4:00 PM EDT
0.7051
-0.0631 (-8.21%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Onconetix Revenue
In the year 2025, Onconetix had annual revenue of $815.37K, down -67.70%. Onconetix had revenue of $303.60K in the quarter ending December 31, 2025, a decrease of -57.36%.
Revenue (ttm)
$815.37K
Revenue Growth
-67.70%
P/S Ratio
0.65
Revenue / Employee
$407,686
Employees
2
Market Cap
532.31K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 815.37K | -1.71M | -67.70% |
| Dec 31, 2024 | 2.52M | 2.47M | 4,217.31% |
| Dec 31, 2023 | 58.47K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionONCO News
- 19 days ago - Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson - GlobeNewsWire
- 26 days ago - Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update - GlobeNewsWire
- 4 weeks ago - Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors - GlobeNewsWire
- 4 weeks ago - Onconetix Highlights Realbotix's Role in Ericsson's World-First 6G Trial Demonstration - GlobeNewsWire
- 5 weeks ago - Onconetix, Inc. Announces 1-for-5 Reverse Stock Split - GlobeNewsWire
- 2 months ago - Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company - GlobeNewsWire
- 2 months ago - Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - Business Wire
- 7 months ago - Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. - GlobeNewsWire